Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 647,278 | 401,325 | 531,163 | 186,781 | 81,770 |
| Marketable Securities | 157,649 | 169,860 | 77,902 | 57,474 | N/A |
| Receivables | 262,012 | 16,181 | N/A | N/A | 7,500 |
| TOTAL | $1,248,203 | $671,217 | $636,381 | $255,232 | $97,247 |
| Non-Current Assets | |||||
| PPE Net | 179,954 | 131,834 | 115,375 | 10,795 | 11,445 |
| Intangibles | 141,104 | 132,264 | 124,099 | 55,040 | 56,735 |
| Other Non-Current Assets | 13,218 | 8,705 | 56,372 | 7,001 | 7,530 |
| TOTAL | $334,276 | $272,803 | $295,846 | $72,836 | $75,710 |
| Total Assets | $1,582,479 | $944,020 | $932,227 | $328,068 | $172,957 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 54,332 | 15,097 | 9,242 | 2,518 | 2,910 |
| Accrued Expenses | 137,390 | 80,843 | 43,768 | 12,035 | 19,945 |
| Other current liabilities | 8,860 | 5,604 | 1,470 | 1,316 | 1,262 |
| TOTAL | $579,672 | $239,218 | $213,331 | $18,982 | $25,795 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 273,228 | 81,814 | 158,851 | 3,113 | 1,678 |
| Other Non-Current Liabilities | 335,515 | 532,763 | 531,870 | 330,557 | 333,179 |
| TOTAL | $375,598 | $598,362 | $534,370 | $333,057 | $333,179 |
| Total Liabilities | $955,270 | $837,580 | $747,701 | $352,039 | $358,974 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,859 | 63,660 | 61,278 | 57,959 | 51,529 |
| Common Shares | 714 | 633 | 612 | 539 | 324 |
| Retained earnings | -1,874,199 | -1,696,635 | -1,499,325 | -1,457,665 | -1,431,801 |
| Other shareholders' equity | 7,218 | -5,202 | -12,833 | -14,124 | -12,091 |
| TOTAL | $627,209 | $106,440 | $184,526 | $-23,971 | $-186,017 |
| Total Liabilities And Equity | $1,582,479 | $944,020 | $932,227 | $328,068 | $172,957 |